Veterinary Medicines

Scourguard 3 Lyophilisat et solvant pour solution injectable

Authorised
  • Bovine coronavirus, strain Hansen, Live
  • Bovine rotavirus A, strain Lincoln, Live
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
Download as PDF

Product identification

Medicine name:
Scourguard 3 Lyophilisat et solvant pour solution injectable
Scourguard 3 Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung
Active substance:
  • Bovine coronavirus, strain Hansen, Live
  • Bovine rotavirus A, strain Lincoln, Live
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
Target species:
  • Cattle (pregnant cow)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine coronavirus, strain Hansen, Live
    7.50
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
  • Bovine rotavirus A, strain Lincoln, Live
    100000000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (pregnant cow)
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AI01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Scourguard 3 Lyophilisate and solvent for solution for injection - 5 vial with lyophilisate and 1 vial of 10 ml with solvent
  • Scourguard 3 Lyophilisate and solvent for solution for injection - 25 vial with lyophilisate and 25 vial of 2 ml with solvent
  • Scourguard 3 Lyophilisate and solvent for solution for injection - 1 vial with lyophilisate and 1 vial of 2 ml with solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 087/93/11/0255
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 13/03/2025
Download